Cansortium Inc. (OTCMKTS:CNTMF) Short Interest Down 83.9% in June

Cansortium Inc. (OTCMKTS:CNTMF) was the recipient of a large drop in short interest in June. As of June 30th, there was short interest totaling 41,835 shares, a drop of 83.9% from the June 15th total of 260,061 shares. Based on an average daily trading volume, of 1,061,571 shares, the short-interest ratio is currently 0.0 days.

Cansortium Price Performance

OTCMKTS CNTMF traded down $0.00 on Friday, hitting $0.02. The company had a trading volume of 652,397 shares, compared to its average volume of 454,394. The company’s fifty day moving average price is $0.02 and its 200-day moving average price is $0.03. Cansortium has a 12-month low of $0.02 and a 12-month high of $0.09.

Cansortium (OTCMKTS:CNTMF) last posted its quarterly earnings data on Thursday, April 30th. The company reported ($0.16) earnings per share (EPS) for the quarter. During the same quarter last year, the firm earned ($0.14) EPS.

Cansortium Company Profile

Cansortium, Inc (OTCMKTS:CNTMF) is a vertically integrated cannabis company engaged in the cultivation, manufacturing, distribution and retail of medical cannabis products in the United States. The company’s operations span from seed to sale, with dedicated cultivation facilities, extraction labs and a network of dispensaries serving registered patients.

Cansortium holds licenses and operates in multiple jurisdictions, including Florida, Pennsylvania, Louisiana, Texas and Puerto Rico. Its product portfolio encompasses cannabis flower, pre-rolls, concentrates, vape cartridges, oils, edibles and topicals, offered under brands such as The+Source, Chroma and Campfire, alongside its private-label formulations.

Founded in 2017 and headquartered in Miami, Cansortium began dispensary operations in Florida in 2018 and has since expanded its footprint into new markets.